The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Open accessAbstract
Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As an example, the most common Cas9 system, SpCas9, recognises NGG motifs and therefore only sequences adjacent to that motif can be targeted [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR systems might be an alternative or a tool to use together with conventional antibiotics, either by disabling antibiotic-resistance genes or by developing toxicity in bacteria through the cleavage of crucial domains of their genome, exerting a bactericidal effect [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In early 2013, Jiang et al. used the CRISPR-Cas9 system to induce targeted mutations (insertions, deletions, and single-nucleotide substitutions) in the genome of Streptococcus pneumoniae and E. coli strains [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
In the citing paper
“The type II CRISPR/Cas9 system has been exploited for high-efficiency gene editing in model microorganisms such as E. coli (Jiang et al., 2015), S. cerevisiae (DiCarlo et al., 2013), and Streptococcus pneumoniae (Jiang et al., 2013).”
From Gas Fermentation—A Flexible Platform for Commercial Scale Production of Low-Carbon-Fuels and Chemicals from Waste and Renewable Feedstocks (2016) · cites this paper as Jiang et al., 2013
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [93]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationEnzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 10,088
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Cited by
Sorted by citations
Items 901–1,000 of 1,007
Efficient retroelement-mediated DNA writing in bacteria
Farzadfard, F., Gharaei, N., Citorik, R. J., & Lu, T. K. (2021) · Cell Systems · doi:10.1016/j.cels.2021.07.001 · Cited by 39
Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria
Collias, D., Vialetto, E., Yu, J., Co, K., Almási, É. D. H., Rüttiger, A.-S., Achmedov, T., Strowig, T., & Beisel, C. L. (2023) · Nature Communications · doi:10.1038/s41467-023-36283-9 · Cited by 37
A multiplex CRISPR interference tool for virulence gene interrogation in Legionella pneumophila
Ellis, N. A., Kim, B., Tung, J., & Machner, M. P. (2021) · Communications Biology · doi:10.1038/s42003-021-01672-7 · Cited by 34
Paving the way towards precise and safe CRISPR genome editing
Śledziński, P., Dabrowska, M., Nowaczyk, M., & Olejniczak, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107737 · Cited by 43
Characterization of Cme and Yme thermostable Cas12a orthologs
Fuchs, R. T., Curcuru, J. L., Mabuchi, M. Y., Noireterre, A., Weigele, P., Sun, Z., & Robb, G. B. (2022) · Communications Biology · doi:10.1038/s42003-022-03275-2 · Cited by 41
Specific targeting of plasmids with Argonaute enables genome editing
Esyunina, D., Okhtienko, A., Olina, A., Panteleev, V., Prostova, M. A., Aravin, A. A., & Kulbachinskiy, A. V. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad191 · Cited by 39
Liang, P., Lv, B., Chen, K., Qiao, W., & Li, D. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341950 · Cited by 39
A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila
Jiang, X., Ren, X., Sun, J., Wang, X., Qiao, H., Xu, B., Liu, L., & Ni, J. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.02.007 · Cited by 39
Enhancer-associated RNAs as therapeutic targets
Léveillé, N., Melo, C. A., & Agami, R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1029452 · Cited by 38
A New Era of Genome Integration—Simply Cut and Paste!
Liu, Z., Liang, Y., Ang, E. L., & Zhao, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00331 · Cited by 39
Liu, S.-D., Wu, Y., Wang, T., Zhang, C., & Xing, X. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00247 · Cited by 39
Oesterle, S., Gerngross, D., Schmitt, S., Roberts, T. M., & Panke, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12395-3 · Cited by 39
Tang, Q., Lu, T., & Liu, S. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00430 · Cited by 39
Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis
Hong, K., Liu, D., Chen, T., & Wang, Z. (2018) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-018-2537-1 · Cited by 39
Regulation of cyclic oligoadenylate synthesis by the Staphylococcus epidermidis Cas10-Csm complex
Nasef, M., Muffly, M. C., Beckman, A. B., Rowe, S. J., Walker, F. C., Hatoum-Aslan, A., & Dunkle, J. A. (2019) · RNA · doi:10.1261/rna.070417.119 · Cited by 39
Construction of a bacterial surface display system based on outer membrane protein F
Chen, T., Wang, K., Chi, X., Zhou, L., Li, J., Liu, L., Zheng, Q., Wang, Y., Yu, H. J., Gu, Y., et al. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1120-2 · Cited by 39
A Two-Enzyme Adaptive Unit within Bacterial Folate Metabolism
Schober, A. F., Mathis, A. D., Ingle, C., Park, J. O., Chen, L., Rabinowitz, J. D., Junier, I., Rivoire, O., & Reynolds, K. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.030 · Cited by 37
Mitsui, R., Yamada, R., & Ogino, H. (2019) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-019-2688-8 · Cited by 39
Huang, C., Ding, T., Wang, J., Wang, X., Guo, L., Wang, J., Zhu, L. F., Bi, C., Zhang, X., Ma, X., et al. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10104-w · Cited by 38
Erwood, S., Laselva, O., Bily, T. M. I., Brewer, R. A., Rutherford, A. H., Bear, C. E., & Ivakine, E. A. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.002 · Cited by 40
Engineering regulatory networks for complex phenotypes in E. coli
Liu, R., Liang, L., Freed, E. F., Choudhury, A., Eckert, C. A., & Gill, R. T. (2020) · Nature Communications · doi:10.1038/s41467-020-17721-4 · Cited by 37
CRISPR/Cas9‐mediated genome editing of Schistosoma mansoni acetylcholinesterase
You, H., Mayer, J. U., Johnston, R. L., Sivakumaran, H., Ranasinghe, S. L., Rivera, V., Kondrashova, O., Koufariotis, L. T., Du, X., Driguez, P., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001745rr · Cited by 38
Recording of elapsed time and temporal information about biological events using Cas9
Park, J., Lim, J. M., Jung, I., Heo, S., Park, J., Chang, Y. J., Kim, H. K., Jung, D., Yu, J. H., Min, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.014 · Cited by 35
Role of extremophiles and their extremozymes in biorefinery process of lignocellulose degradation
Chettri, D., Verma, A. K., Sarkar, L., & Verma, A. K. (2021) · Extremophiles · doi:10.1007/s00792-021-01225-0 · Cited by 39
A ligation-driven CRISPR–Cas biosensing platform for non-nucleic acid target detections
Zhao, J., Tan, Z., Wang, L., Lei, C., & Nie, Z. (2021) · Chemical Communications · doi:10.1039/d1cc02578c · Cited by 39
New frontiers in mucosal health in aquaculture
Beck, B. H., & Peatman, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417186-2.00013-3 · Cited by 39
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
Alves, E., Taifour, S., Dolcetti, R., Chee, J., Nowak, A. K., Gaudieri, S., & Blancafort, P. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.04.009 · Cited by 40
CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
Balcha, F. B., & Neja, S. A. (2023) · Animal Diseases · doi:10.1186/s44149-023-00065-z · Cited by 44
Cheng, Y., Wang, H., & Li, M. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108524 · Cited by 45
Application of CRISPR/Cas9 Technology to HBV
Lin, G., Zhang, K., & Li, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125950 · Cited by 41
Building biological foundries for next-generation synthetic biology
Chao, R., Yuan, Y., & Zhao, H. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4866-8 · Cited by 38
Simple, Efficient CRISPR-Cas9-Mediated Gene Editing in Mice: Strategies and Methods
Low, B. E., Kutny, P. M., & Wiles, M. V. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_2 · Cited by 38
Schiml, S., Fauser, F., & Puchta, H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-4931-1_8 · Cited by 37
Using the CRISPR/Cas9 system to eliminate native plasmids of Zymomonas mobilis ZM4
Cao, Q., Shao, H., Qiu, H., Li, T., Zhang, Y., & Tan, X. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1189312 · Cited by 38
RAPID COMMUNICATION: Generation of FGF5 knockout sheep via the CRISPR/Cas9 system12
Hu, R., Fan, Z., Wang, B. Y., Deng, S., Zhang, X., Zhang, J. L., Han, H., & Lian, Z. (2017) · Journal of Animal Science · doi:10.2527/jas.2017.1503 · Cited by 41
Mitousis, L., Thoma, Y., & Musiol-Kroll, E. M. (2020) · Antibiotics · doi:10.3390/antibiotics9080494 · Cited by 41
CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering
Saifaldeen, M., Al-Ansari, D. E., Ramotar, D., & Aouida, M. (2020) · Cells · doi:10.3390/cells9112518 · Cited by 40
He, Y., Kuang, X., Long, T., Li, G., Ren, H., He, B., Yan, J.-R., Liao, X., Liu, Y., Chen, L., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab368 · Cited by 40
Advances in the Development of Phage-Based Probes for Detection of Bio-Species
Paramasivam, K., Shen, Y., Yuan, J., Waheed, I., Mao, C., & Zhou, X. (2022) · Biosensors · doi:10.3390/bios12010030 · Cited by 41
Genetic engineering as a powerful tool to improve probiotic strains
Bravo, D., & Landete, J. M. (2017) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2017.1408257 · Cited by 37
A CRISPR way to engineer the human genome
Ramalingam, S., Annaluru, N., & Chandrasegaran, S. (2013) · Genome biology · doi:10.1186/gb-2013-14-2-107 · Cited by 37
Minaba, M., & Kato, Y. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03417-13 · Cited by 36
CRISPR as a strong gene editing tool
Shen, S., Loh, T. J., Shen, H., Zheng, X., & Shen, H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.1.128 · Cited by 42
Maxwell, C. S., Jacobsen, T. L., Marshall, R., Noireaux, V., & Beisel, C. L. (2018) · Methods · doi:10.1016/j.ymeth.2018.02.016 · Cited by 35
CRISPR‐Enabled Tools for Engineering Microbial Genomes and Phenotypes
Tarasava, K., Oh, E. J., Eckert, C. A., & Gill, R. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700586 · Cited by 37
CRISPR-Cas immunity, DNA repair and genome stability
Cubbon, A., Ivančić-Baće, I., & Bolt, E. L. (2018) · Bioscience Reports · doi:10.1042/bsr20180457 · Cited by 39
You, Z., Ye, X., Ye, L., Qian, Q., Wu, M., Song, J. T., Che, J., & Zhong, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-34150-y · Cited by 37
Recent advances in plasmid-based tools for establishing novel microbial chassis
Nora, L. C., Westmann, C. A., Guazzaroni, M., Siddaiah, C. N., Gupta, V. K., & Silva‐Rocha, R. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107433 · Cited by 38
Expanding and understanding the CRISPR toolbox for Bacillus subtilis with MAD7 and dMAD7
Price, M. A., Cruz, R., Bryson, J. W., Escalettes, F., & Rosser, S. J. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27312 · Cited by 37
Occurrence and Diversity of CRISPR Loci in Lactobacillus casei Group
Yang, L., Li, W., Ujiroghene, O. J., Yang, Y., Lu, J., Zhang, S., Pang, X., & Lv, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00624 · Cited by 37
Piñero‐Lambea, C., García-Ramallo, E., Martínez, S., Delgado, J., Serrano, L. G., & Lluch‐Senar, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00022 · Cited by 38
Harnessing the type I CRISPR‐Cas systems for genome editing in prokaryotes
Xu, Z., Li, Y., Li, M., Xiang, H., & Yan, A. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15116 · Cited by 38
Efficient Multiplex Genome Editing in Streptomyces via Engineered CRISPR-Cas12a Systems
Zhang, J., Zhang, D., Zhu, J., Liu, H., Liang, S., & Luo, Y. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00726 · Cited by 37
Strategies for Bacteriophage T5 Mutagenesis: Expanding the Toolbox for Phage Genome Engineering
Ramirez-Chamorro, L., Boulanger, P., & Rossier, O. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.667332 · Cited by 37
Targeted genetic screening in bacteria with a Cas12k-guided transposase
Chen, W., Ren, Z.-H., Tang, N., Chai, G., Zhang, H., Zhang, Y., Ma, J., Wu, Z., Shen, X., Huang, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109635 · Cited by 35
Closely related type II-C Cas9 orthologs recognize diverse PAMs
Wei, J., Hou, L., Liu, J., Wang, Z., Gao, S., Qi, T., Gao, S., Sun, S., & Wang, Y. (2022) · eLife · doi:10.7554/elife.77825 · Cited by 38
CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAsPreprint
Lee, H. J., Kim, H. J., & Lee, S. J. (2020) · Genome Research · doi:10.1101/gr.257493.119 · Cited by 37
Zhang, M., Gong, Z., Tang, J., Lu, F., Li, Q., & Zhang, X. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01798-1 · Cited by 36
A new method for the detection of Mycobacterium tuberculosis based on the CRISPR/Cas system
Zhang, X., He, X., Zhang, Y., Chen, L., Pan, Z., Huang, Y., & Li, H. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08656-4 · Cited by 36
CRISPR-M: Predicting sgRNA off-target effect using a multi-view deep learning network
Sun, J., Guo, J. H., & Liu, J. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011972 · Cited by 39
An Integrated System for Precise Genome Modification in Escherichia coli
Taş, H., Nguyen, C. T., Patel, R., Kim, N. H., & Kuhlman, T. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136963 · Cited by 36
A CRISPR CASe for high-throughput silencing
Heintze, J., Luft, C., & Ketteler, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00193 · Cited by 38
Resistance and tolerance to foreign elements by prokaryotic immune systems — curating the genome
Goldberg, G. W., & Marraffini, L. A. (2015) · Nature reviews. Immunology · doi:10.1038/nri3910 · Cited by 39
High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges
Wade, M. R. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115587916 · Cited by 39
Jo, Y.-I., Suresh, B., Kim, S., & Ramakrishna, S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.09.003 · Cited by 36
Developing a Cas9‐based tool to engineer native plasmids in Synechocystis sp. PCC 6803
Xiao, Y., Wang, S., Rommelfanger, S. R., Balassy, A., Barba‐Ostria, C., Gu, P., Galazka, J. M., & Zhang, F. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26747 · Cited by 36
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
Yoshida, M., Yokota, E., Sakuma, T., Yamatsuji, T., Takigawa, N., Ushijima, T., Yamamoto, T., Fukazawa, T., & Naomoto, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.25678 · Cited by 36
Zhu, M., Sun, L., Lu, X., Zong, H., & Zhuge, B. (2019) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2019.03.009 · Cited by 36
CRISPR-Cas9-mediated genome editing in vancomycin-resistant Enterococcus faecium
de Maat, V., Stege, P. B., Dedden, M., Hamer, M., van Pijkeren, J., Willems, R. J. L., & van Schaik, W. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz256 · Cited by 36
Ghodke, H. B., Ho, H. N., & van Oijen, A. M. (2020) · Nature Communications · doi:10.1038/s41467-020-15179-y · Cited by 36
Schilling, C., Koffas, M. A. G., Sieber, V., & Schmid, J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00424 · Cited by 34
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML
Trinh, B. Q., Ummarino, S., Zhang, Y., Ebralidze, A. K., Bassal, M. A., Nguyen, T. M., Heller, G., Coffey, R., Tenen, D. E., van der Kouwe, E., et al. (2021) · Blood · doi:10.1182/blood.2020007920 · Cited by 35
Helicase-AID: A novel molecular device for base editing at random genomic loci
Wang, J., Zhao, D., Li, J., Hu, M., Xin, X., Price, M. A., Li, Q., Liu, L., Li, S., Rosser, S. J., et al. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.08.005 · Cited by 36
Vereecke, N., Kvisgaard, L. K., Baele, G., Boone, C., Kunze, M., Larsen, L. E., Theuns, S., & Nauwynck, H. (2022) · Virus Evolution · doi:10.1093/ve/veac053 · Cited by 36
Cengic, I., Cañadas, I. C., Minton, N. P., & Hudson, E. P. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00375 · Cited by 33
Computational design of CRISPR guide RNAs to enable strain-specific control of microbial consortia
Rottinghaus, A. G., Vo, S., & Moon, T. S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213154120 · Cited by 36
CRISPR/Cas9 Editing of the Bacillus subtilis Genome
Burby, P. E., & Simmons, L. A. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2272 · Cited by 36
Lyimo, B. M., Popkin-Hall, Z. R., Giesbrecht, D., Mandara, C. I., Madebe, R. A., Bakari, C., Pereus, D., Seth, M. D., Ngamba, R., Mbwambo, R. B., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.757844 · Cited by 33
Precise probiotic therapy: Advances, bottlenecks, and the road to microbiome-informed nutrition
Jiang, Y., Jiang, S., Wang, Z., Zhu, P., Zhang, J., Teng, F., & Huang, S. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2623359 · Cited by 41
Chen, X., Li, M., Feng, X., & Guang, S. (2015) · Genetics · doi:10.1534/genetics.115.181883 · Cited by 34
Taylor, J., & Woodcock, S. A. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115590069 · Cited by 35
Czajka, J. J., Wang, Q., Wang, Y., & Tang, Y. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8489-9 · Cited by 35
Sanjurjo-Soriano, C., & Kalatzis, V. (2018) · Neural Plasticity · doi:10.1155/2018/5056279 · Cited by 38
Zhang, Y., Feng, J., Wang, P., Xia, J., Li, X., & Zou, X. (2019) · Gene · doi:10.1016/j.gene.2019.04.079 · Cited by 34
CRISPR technology for genome editing
Bhattacharjee, G., Mani, I., Gohil, N., Khambhati, K., Braddick, D., Panchasara, H., & Singh, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00007-1 · Cited by 36
Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment
Wu, X., Ma, W., Mei, C., Chen, X., Yao, Y., Liu, Y., Qin, X., & Yuan, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01603-0 · Cited by 36
Sense-overlapping lncRNA as a decoy of translational repressor protein for dimorphic gene expression
Perez, C. A. G., Adachi, S., Nong, Q. D., Adhitama, N., Matsuura, T., Natsume, T., Wada, T., Kato, Y., & Watanabe, H. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009683 · Cited by 36
Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
Al-Sammarraie, N., & Ray, S. K. (2021) · Cells · doi:10.3390/cells10092342 · Cited by 36
CRISPR/Cas Technologies and Their Applications in Escherichia coli
Dong, H., Cui, Y., & Zhang, D. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.762676 · Cited by 35
Shi, Y.-J., Duan, M., Ding, J., Wang, F.-Q., Bi, L.-L., Zhang, C.-X., Zhang, Y., Duan, J.-Y., Huang, A.-H., Lei, X., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.032 · Cited by 35
The genome editing toolbox: a spectrum of approaches for targeted modification
Cheng, J. K., & Alper, H. S. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.06.005 · Cited by 34
Moyer, T. C., & Holland, A. J. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.03.017 · Cited by 35
Frank, S., Skryabin, B. V., & Greber, B. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-773 · Cited by 34
Multi-gene engineering in plants with RNA-guided Cas9 nuclease
Raitskin, O., & Patron, N. J. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.11.008 · Cited by 38
Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems
Heussler, G. E., & O’Toole, G. A. (2016) · Journal of Bacteriology · doi:10.1128/jb.00086-16 · Cited by 34
Lu, S., Shen, X., & Chen, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-03233-7 · Cited by 34
Harnessing the natural diversity and in vitro evolution of Cas9 to expand the genome editing toolbox
Karvelis, T., Gasiūnas, G., & Šikšnys, V. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.009 · Cited by 33
Methods for the genetic manipulation of marine bacteria
Zeaiter, Z., Mapelli, F., Crotti, E., & Borin, S. (2018) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2018.03.003 · Cited by 35
Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference
Sato’o, Y., Hisatsune, J., Yu, L., Sakuma, T., Yamamoto, T., & Sugai, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0185987 · Cited by 34
Protein Engineering Strategies to Expand CRISPR-Cas9 Applications
Ribeiro, L. F., Ribeiro, L. F. C., Barreto, M. Q., & Ward, R. J. (2018) · International Journal of Genomics · doi:10.1155/2018/1652567 · Cited by 36
Metadata
- Authors
- Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A.
- Affiliations
- Rockefeller University (US)
- Broad Institute (US)
- Corresponding author
- Bikard, David
- Marraffini, Luciano A
- Venue
- Nature Biotechnology
- Published
- 2013-01-29
- Volume
- 31
- Issue
- 3
- Pages
- 233-239
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3748948
- OpenAlex
- W2000046950
- Cited by
- 2,429
- References
- 51
- Citations by year
- 2026: 84 · 2025: 124 · 2024: 151 · 2023: 162 · 2022: 199 · 2021: 203 · 2020: 245 · 2019: 185 · 2018: 206 · 2017: 208 · 2016: 203 · 2015: 174 · 2014: 183 · 2013: 98
- FWCI
- 98.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- U.S. Public Health Service
- National Institute of Mental Health (DP1MH100706)
- National Institute of General Medical Sciences (T32GM007753)
- National Institute of Allergy and Infectious Diseases (DP2AI104556)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, bacterial genome editing, Streptococcus pneumoniae, Escherichia coli, targeted mutagenesis, recombineering, genome editing
- MeSH terms
- Base Sequence, Endonucleases, Escherichia coli, Genetic Engineering, Molecular Sequence Data, Streptococcus pneumoniae, Mutagenesis, Site-Directed, Genome, Bacterial, DNA Cleavage, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
